PD-033: Cetuximab + RT shows an excellent long term OS in patients with both high ADCC and high EGFR
Authors:
- M. MerlanoMMM. Merlano
- L. LattanzioLLL. Lattanzio
- N. DenaroNDN. Denaro
- D. VivenzaDVD. Vivenza
- G. MilanoGMG. Milano
- R. Vigna TagliantiRTR. Vigna Taglianti
- A. MerlottiAMA. Merlotti
- M. FerreroMFM. Ferrero
- C. Lo NigroCNC. Lo Nigro
- 1 March 2017
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 19-20